These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18805440)

  • 1. DNA methylation and TLR9 ligands: not only a matter of semantics.
    Baldari CT
    Immunol Lett; 2008 Nov; 121(1):84-5. PubMed ID: 18805440
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunophysiological impact of bacterial CpG DNA on the gut.
    Watson JL; McKay DM
    Clin Chim Acta; 2006 Feb; 364(1-2):1-11. PubMed ID: 16153626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-induced conformational changes allosterically activate Toll-like receptor 9.
    Latz E; Verma A; Visintin A; Gong M; Sirois CM; Klein DC; Monks BG; McKnight CJ; Lamphier MS; Duprex WP; Espevik T; Golenbock DT
    Nat Immunol; 2007 Jul; 8(7):772-9. PubMed ID: 17572678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis.
    Gäbele E; Mühlbauer M; Dorn C; Weiss TS; Froh M; Schnabl B; Wiest R; Schölmerich J; Obermeier F; Hellerbrand C
    Biochem Biophys Res Commun; 2008 Nov; 376(2):271-6. PubMed ID: 18760996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsins are required for Toll-like receptor 9 responses.
    Matsumoto F; Saitoh S; Fukui R; Kobayashi T; Tanimura N; Konno K; Kusumoto Y; Akashi-Takamura S; Miyake K
    Biochem Biophys Res Commun; 2008 Mar; 367(3):693-9. PubMed ID: 18166152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased suppression of immune stimulatory CpG motifs in plant DNA.
    Wang Y; Zhou J; Liu B
    Immunol Lett; 2007 Dec; 114(2):73-80. PubMed ID: 17889375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of toll-like receptor 9 by DNA from different bacterial species.
    Dalpke A; Frank J; Peter M; Heeg K
    Infect Immun; 2006 Feb; 74(2):940-6. PubMed ID: 16428738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 9 processing: the key event in Toll-like receptor 9 activation?
    Bauer S
    Immunol Lett; 2013 Jan; 149(1-2):85-7. PubMed ID: 23183093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sweetness of the DNA backbone drives Toll-like receptor 9.
    Wagner H
    Curr Opin Immunol; 2008 Aug; 20(4):396-400. PubMed ID: 18656540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil recognition of bacterial DNA and Toll-like receptor 9-dependent and -independent regulation of neutrophil function.
    El Kebir D; József L; Filep JG
    Arch Immunol Ther Exp (Warsz); 2008; 56(1):41-53. PubMed ID: 18250968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vitro and in ovo responses of chickens to TLR9 subfamily ligands.
    Jenkins KA; Lowenthal JW; Kimpton W; Bean AG
    Dev Comp Immunol; 2009 May; 33(5):660-7. PubMed ID: 19100284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory molecules required for nucleotide-sensing Toll-like receptors.
    Saitoh S; Miyake K
    Immunol Rev; 2009 Jan; 227(1):32-43. PubMed ID: 19120473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minding the Cs and Gs.
    Krieg AM
    Mol Ther; 2000 Mar; 1(3):209-10. PubMed ID: 10933935
    [No Abstract]   [Full Text] [Related]  

  • 15. Phosphorothioate-modified TLR9 ligands protect cancer cells against TRAIL-induced apoptosis.
    Chiron D; Pellat-Deceunynck C; Maillasson M; Bataille R; Jego G
    J Immunol; 2009 Oct; 183(7):4371-7. PubMed ID: 19734228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation.
    Peter ME; Kubarenko AV; Weber AN; Dalpke AH
    J Immunol; 2009 Jun; 182(12):7690-7. PubMed ID: 19494293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.
    McCluskie MJ; Krieg AM
    Curr Top Microbiol Immunol; 2006; 311():155-78. PubMed ID: 17048708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseless assumptions: activation of TLR9 by DNA.
    Gangloff M; Gay NJ
    Immunity; 2008 Mar; 28(3):293-4. PubMed ID: 18342000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular cell responsiveness to Toll-like receptor ligands in carotid atheroma.
    Erridge C; Burdess A; Jackson AJ; Murray C; Riggio M; Lappin D; Milligan S; Spickett CM; Webb DJ
    Eur J Clin Invest; 2008 Oct; 38(10):713-20. PubMed ID: 18837796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial DNA activates endothelial cells and promotes neutrophil adherence through TLR9 signaling.
    El Kebir D; József L; Pan W; Wang L; Filep JG
    J Immunol; 2009 Apr; 182(7):4386-94. PubMed ID: 19299739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.